1 time · proinvestor.com
Anavex Positive OLE-Alzheimer 192 ugers data April 2025
" Blarcamesine, a small molecule administered orally once daily, has numerically superior clinical efficacy to approved therapies while also slowing neurodegeneration in early AD patients.
Les artikkel